Your browser doesn't support javascript.
loading
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.
Shah, A Y; Kotecha, R R; Lemke, E A; Chandramohan, A; Chaim, J L; Msaouel, P; Xiao, L; Gao, J; Campbell, M T; Zurita, A J; Wang, J; Corn, P G; Jonasch, E; Motzer, R J; Sharma, P; Voss, M H; Tannir, N M.
  • Shah AY; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ayshah@mdanderson.org.
  • Kotecha RR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lemke EA; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Chandramohan A; Department of Diagnostic Radiology, MD Anderson Cancer Center, Houston, TX, USA.
  • Chaim JL; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Msaouel P; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Xiao L; Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA.
  • Gao J; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Campbell MT; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Zurita AJ; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Wang J; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Corn PG; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Jonasch E; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Motzer RJ; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sharma P; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Voss MH; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tannir NM; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Eur J Cancer ; 114: 67-75, 2019 06.
Article en En | MEDLINE | ID: mdl-31075726
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Factor A de Crecimiento Endotelial Vascular / Inhibidores de Proteínas Quinasas / Inmunoterapia / Neoplasias Renales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Factor A de Crecimiento Endotelial Vascular / Inhibidores de Proteínas Quinasas / Inmunoterapia / Neoplasias Renales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article